Upper Gastrointestinal Biopsy

Publication Date: October 1, 2015

Key Points

Key Points

The purpose of the current guideline is to establish evidence-based practicing standards for the performance of biopsies of normal-appearing mucosa in the upper gastrointestinal tract.

Dyspepsia is defined according to the Rome III criteria, which include ≥1 of the following symptoms: bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning.

The guideline assumes no prior treatment for Helicobacter pylori (HP) infection.

Diagnosis

...iagnos...

...e III Criteria for Functional Dyspeps...


...pper-Gastrointestinal Biopsy to Evaluate...


Summary of Recommendations from the AGA Guideline on Upper-GI Biopsies to Evaluate Adult Dyspepsia

...ummary of Recommendations from the AG...

...patients undergoing EGD for dyspepsia as the s...


...mmunocompetent patients undergoing EGD for dyspeps...

...munocompromised patients undergoing EGD...

...ng biopsies from the normal-appearing gastri...

...sies are obtained from the normal-appear...


... In patients undergoing EGD for dysp...

...unocompromised patients undergoing EGD...

...biopsies are obtained from the nor...


Locations of Gastric Biopsy Recommended by the Updated Sydney System

...s of Gastric Biopsy Recommended by...